Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: A study with monoclonal antibody

Human Pathology

Volumn 30, Issue 2, 1999, Pages 168-172

  Zhang, Paul J ^a,b   Driscoll, Deborah L ^a   Lee, Hsiang Kuang ^a   Nolan, Colleen ^a   Velagapudi, Satish R C ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Immunohistochemistry; Monoclonal antibody; Prostate inhibin peptide; Prostatic carcinoma

Indexed keywords

INHIBIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE SECTION;

EID: 0032979517     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90271-X     Document Type: Article

References (13)

1. Burger HG, McLachlan RI, Robertson DM, et al: Inhibin and the regulation of testicular function. Historical and clinical aspects. Ann N Y Acad Sci 564:1-9, 1989
2. Bardin CW, Morris PL, Shaha C, et al: Inhibin structure and function in the testis. Ann N Y Acad Sci 564:10-23, 1989
3. Ying SY: Inhibins, activins and follistatins. J Steroid Biochem 33:705-713, 1989
4. Beksac MS, Khan SA, Eliasson R, et al: Evidence for the prostatic origin of immunoreactive inhibin like material in human seminal plasma. Int J Androl 7:389-397, 1984
5. Shah MG, Sheth AR: Similarities in the modulation of pituitary and prostatic FSH by inhibin and related peptides. Prostate 18:1-8, 1991
6. Garde SV, Sheth AR, Venkatesan VM, et al: Prostate inhibin peptide (PIP) in prostate cancer: A comparative immunohistochemical study with prostate specific antigen (PSA) and prostatic acid phosphatase (PAP). Cancer Letters 78:11-17, 1994
7. Dube JY, Pelletier G, Gagnon P, et al: Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue, in primary prostatic tumors and in their metastases. J Urology 138:883-887, 1987
8. Whitmore WF, Jr: Natural history and staging of prostate cancer. Urol Clin North Am 11:205-220, 1984
9. Renshaw AA, Chang H, D'amico AV: Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol 107:704-708, 1997
10. Doctor VM, Sheth AR, Simha MM, et al: Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: Comparison of its distribution in normal, benign and malignant prostates. Br J Cancer 53:547-554, 1986
11. Teni TR, Sheth AR, Kamath MR, et al: Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate. Cancer Letters 43:9-14, 1988
12. Sheth AR, Garde SV, Mehta MK, et al: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide. Indian J Exp Biol 30:157-161, 1992
13. Garde S, Sheth A, Porter AT, et al: Effect of prostatic inhibin peptide on prostate cancer cell growth in vitro and in vivo. Prostate 22:225-233, 1993